June 21, 2024 — Cardiomatics, a pioneer in AI-powered ECG analysis solutions, and the Biotronik sales organization for Germany, a leading medical technology company in the field of cardiac rhythm management, have agreed upon a sales cooperation. This cooperation aims to accelerate the adoption of artificial intelligence in the early detection and management of individuals susceptible to cardiac events.
As part of the cooperation, Biotronik will distribute Cardiomatics' AI-powered ECG analysis solution alongside its net_ECG advanced ECG-Patch Holter Monitor in Germany. This combined offering will provide healthcare professionals with enhanced capabilities for precise cardiac monitoring and analysis.
"Biotronik is one of the leading companies in the cardiac rhythm management devices market. Their commitment to saving lives and improving patients' quality of life is very well aligned with Cardiomatics aims to make cardiac diagnostics more accurate, fast, and easy. We believe that our AI-based ECG analysis software will create great synergies with the Biotronik ECG-Patch product portfolio and will nicely fit into the journey of cardiac patients." - says Rafał Samborski, CEO of Cardiomatics.
The significance of this cooperation is underlined by the alarming statistics surrounding cardiovascular disease, the leading cause of global mortality. With approximately 17.9[1]million annual deaths attributed to cardiovascular complications, the imperative for improved early detection and management is clear. Studies suggest that up to 80%[2] of premature heart attacks and strokes could be prevented with timely intervention.
”I am excited about the potential of AI to help early detection of cardiac rhythm abnormalities. The partnership between Cardiomatics and Biotronik is a promising step towards integrating this cutting-edge technology with patient care to improve outcomes for those at risk of cardiac events” - says Prof. Dr. David Duncker, Head of Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Cardiomatics has been at the forefront of developing AI solutions to enhance diagnostic cardiology since 2018, to make diagnostic cardiology more insightful, productive, and enjoyable. The Cardiomatics platform has analyzed over 250 thousand long-term ECG signals and garnered the distinction of being the first in its category to receive EU-MDR certification in October 2023.
"By combining Cardiomatics´ cutting-edge AI-powered ECG analysis solution with our net_ECG advanced ECG-Patch Holter Monitor, we aim to revolutionize the early detection and management of cardiac events. This collaboration supports our commitment to providing innovative solutions that enhance patient care and outcomes in cardiovascular health", says Oliver Rehermann, Director of Marketing, e-Health & Connected Cardiac Care, Biotronik Germany.
For more information: http://cardiomatics.com
[1] https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
[2] https://world-heart-federation.org/news/deaths-from-cardiovascular-disease-surged-60-globally-over-the-last-30-years-report/
November 21, 2023 
